Refresh

Krebs Biochemicals & Industries Ltd. - Research Center

524518 KREBSBIO Group (T) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

50.42 52.13 59.70 53.70 33.41
Expenses

Material consumed

9.13 27.56 40.64 25.95 15.86

Manufacturing expenses

22.01 14.80 33.06 26.28 17.05

Personnel expenses

16.47 15.84 15.30 15.83 15.08

Selling expenses

- - - - -

Adminstrative expenses

11.52 9.72 4.70 3.22 4.05

Expenses capitalised

- - - - -

Cost of sales

59.15 67.91 93.70 71.28 52.04

Operating profit

-8.72 -15.78 -33.99 -17.58 -18.63

Other recurring income

0.45 0.62 1.16 0.62 0.37

Adjusted PBDIT

-8.27 -15.16 -32.84 -16.96 -18.27

Financial expenses

4.69 2.97 5.39 6.28 5.93

Depreciation

6.77 6.56 6.30 5.12 4.68

Other write offs

- - - - -

Adjusted PBT

-19.73 -24.69 -44.53 -28.36 -28.87

Tax charges

- - - - -

Adjusted PAT

- - - - -

Non recurring items

-0.03 0.32 -0.35 0.17 -1.27

Other non cash adjustments

- - - - -

Reported net profit

-19.75 -24.37 -44.87 -28.19 -30.14

Earnigs before appropriation

-270.24 -250.49 -226.12 -181.24 -153.06

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-270.24 -250.49 -226.12 -181.24 -153.06
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com